Suggestions
Paul Hastings
CEO of Nkarta Therapeutics
Professional Background
Paul Hastings has built a remarkable career in the biotechnology and pharmaceutical industries, establishing himself as a leading executive and innovator. As the President and CEO of Nkarta Therapeutics, Inc., a prominent company focused on advanced cell therapy and immunotherapy, he has directed a team committed to emerging therapies that harness the body's own immune system to fight cancer. With an impressive track record at Nkarta, Hastings has previously held key leadership roles at numerous industry-leading organizations. His strategic vision and expertise in biotechnology have made significant contributions to the field, enhancing treatment options and improving patient outcomes.
In addition to his current role, Hastings has a history of success as a Director at ViaCyte, where he played a crucial role in promoting and advancing regenerative medicine technologies. His leadership experience is complemented by his tenure as CEO of OncoMed Pharmaceuticals and QLT Inc., where he focused on the development of novel therapies for serious effects of cancer and other conditions. Paul has also served as the Vice Chair of the Biotechnology Innovation Organization, where he advocated for policies that foster innovation and access to new therapies.
Throughout his career, Hastings has demonstrated a commitment to driving advancements in biotechnology, exemplified by his previous positions as Chair and CEO of the YOUTH RALLY COMMITTEE INC and the Board of Directors at Proteon Therapeutics. His extensive service in various capacities also includes critical roles at numerous organizations such as Genzyme and Chiron, showcasing his adaptability and depth of understanding in this dynamic industry.
Education and Achievements
Paul Hastings earned his Bachelor of Science degree in Pharmacy from the University of Rhode Island. His solid educational foundation has equipped him with a robust understanding of pharmaceutical sciences, which he has applied throughout his extensive career. His academic background has been pivotal in shaping his approach to leadership and innovation in healthcare.
As a recognized leader, Hastings has been instrumental in steering the direction of numerous biotechnology organizations toward future success. His involvement with groups like the California Life Sciences Association (CLSA) and the Bay Area Biosciences Association has enabled him to contribute to the broader dialogue about biotechnology advancements in California and beyond. This participation not only highlights his commitment to the industry but also reflects his collaborative approach to driving progress through shared knowledge and resources.
Moreover, Hastings' experience as a Career Development Trainer at Hoffmann-La Roche underlines his dedication to nurturing talent within the field, enabling the next generation of leaders to thrive in biotechnology.
Achievements
Over the years, Hastings has achieved remarkable success, underscoring his status as a stalwart figure in biotechnology leadership. His tenure at various high-profile companies such as Axys Pharmaceuticals, Genzyme Europe, and Synergen exemplifies his strong business acumen and ability to drive operational excellence. Notably, his leadership at OncoMed Pharmaceuticals allowed for the development and commercialization of therapies that have had a significant impact on patient populations dealing with devastating diseases.
Hastings has also contributed to scientific communication and advocacy, serving as Chair at Proteolix and participating in strategic decision-making processes to guide companies toward impactful research and market introductions. His strategic influence is felt throughout the industry, particularly regarding innovative drug development processes and regulatory affairs, further establishing him as a key player in the pharmaceutical arena.
In summary, Paul Hastings is a highly respected professional with a robust educational background in pharmacy and extensive experience in executive leadership within the biotechnology and pharmaceutical sectors. His successful trajectory reflects a combination of strategic foresight, operational excellence, and an unwavering commitment to patient-centered healthcare solutions. Hastings continues to pave the way for future advancements in the industry, making him a prominent figure to follow for those interested in the future of medical innovation.
Highlights
I can only ask that those of us in our healthcare industry and those who support us and who we pay to do work for us, that think of ourselves as leaders, should ask ourselves what we would do if we had a transgendered child or relative ( or any member of the LGBTQI family) who is sick or who needs care. We want them to be denied that care simply because they are part of a diverse population? I dont think so. Leaders, LEAD, and manage people from all walks of life ( hopefully). Please LEAD and support ALL people, regardless of whether we agree with their lifestyle . I may not be a martian ( substitute with whatever denomination or religion you wish), or support martian values, but I would not deny a martian access to care, EVER. Color the rainbow of walks of life and provide care and discriminate against NONE. That should be an oath. not hindered by laws. I post these things because others don't. I PROUDLY and unapologetically post this, other than to say if its not your juice, dont read it. Also why do we keep going backwards with women’s rights , LGBTQI rights and others ??? Wake up. Don’t accept backwards thinking
MY opinion. As a person with Crohn's disease, and the chair of a patient advocacy organization for people with Crohn's and other diseases of the GI tract and bladder ( www.youthrally.org ) , and as a biotech entrepreneur who believes in the biotech social contract, I find this appalling. There are biosimilars like Coherus' with 85 % price reduction and the branded drug ( and a very good one) continues to dominate. Eli Lilly has a biosimilar, less expensive insulin and the market uptake is similarly muted. To Lilly's credit , and they are at the top of performance in the big pharma industry today, they, themselves created a biosimilar to their OWN branded product. But yet, the dominant insulin products are the branded ones, still.
Why? Because Pharmacy Benefit Managers make MORE money on branded , expensive drugs. There is a flaw in the ecosystem of innovation and reimbursement and reward for innovation.
If some members of congress would spend less time grilling pharma execs on innovation pricing and racking up political points on tic toc and more time understanding the ecosystem, they would understand and get to the root cause of the flaw. Perhaps ask those CEO's how the discounting system works between innovators and PBM's.
If some other members of congress spent less time fighting over basic human rights, and promoting hate and exclusion , and taking away constitutional rights, they could spend the time understanding the perversion of having middlefolk that do NOTHING but gatekeep and collect rebates and pocket them, exposing patients to OUT OF POCKET penalties at the point of purchase ( which is the real cost to patients and their monthly financial planning and the place where patients decide whether to eat or to pay for life saving or altering medicine )
Congress, lets stop with the soundbites and focus on the details and dig in and UNDERSTAND. Perverse incentives for middlefolk to profit dont do anyone good. Give those rebates back to the patients and their care partners through lower out of pocket costs at the pharmacy counter.
The ecosystem will work when less expensive-to- the system Biosimilars , like generics dominate and reduce overall costs to the entire reimbursement ecosystem once an innovative medicine goes off patent. Period. Then we can continue to innovate, and get a reasonable return on that innovation. The cycle will work then , and everyone wins, but notably patients will win , gaining access to new, next generation life altering or life saving innovation.
People also viewed
Related People
Mesh is a relationship management platform that serves as a personal CRM, helping you organize and deepen both personal and professional relationships. It functions as a beautiful rolodex and CRM available on iPhone, Mac, Windows, and web, built automatically to help manage your network efficiently. Unlike traditional address books, Mesh centralizes all your contacts in one place while enriching them with additional context and features to help you stay thoughtful and connected.
Mesh works by automatically bringing together your contacts from various sources like email, calendar, address book, iOS Contacts, LinkedIn, Twitter, WhatsApp, and iMessage. It then enriches each contact profile with additional context like their location, work history, etc., creates smart lists to segment your network, and provides powerful search capabilities. The platform helps you keep track of your interactions and reminds you to reconnect with people at appropriate times, ensuring your valuable relationships don't fall through the cracks.
Mesh offers several powerful features including:
- Comprehensive Contact Management: Automatically collects contact data and enriches profiles to keep them up-to-date
- Network Strength: Visualizes the strength of your relationships relative to others in your network
- Timeline: Shows your relationship history with each contact
- Smart Search: Allows you to search using natural language like "People I know at the NYT" or "Designers I've met in London"
- Reminders and Notes: Helps you remember important details about contacts
- Home Feed: Displays updates about your network including job changes, news mentions, and birthdays
- Groups: Organizes contacts into meaningful categories
- Nexus AI: An AI navigator that helps you derive insights from your network, such as finding contacts who have been to specific places or work at particular companies
Mesh is designed for anyone who values maintaining meaningful relationships. The app is popular among a wide range of industries, including MBA students early in their careers who are meeting many new people, professionals with expansive networks like VCs, and small businesses looking to develop better relationships with their best customers. It’s even used by half the Fortune 500! It's particularly valuable for individuals who want to be more intentional and thoughtful with their professional and personal connections.
Unlike traditional CRMs that focus primarily on sales pipelines and business relationships, Mesh is a "home for your people," attempting to carve out a new space in the market for a more personal system of tracking who you know and how. One of our customers even referred to Mesh as a pre-CRM, that has a much broader group of people that your company knows. Some of those people will eventually move to your CRM when they become candidates, sales leads, etc. Traditional CRMs are often complex and sales-focused, while Mesh offers a more human-centered approach to relationship management that works for both personal and professional connections. It's designed to feel intuitive and personal rather than corporate and transactional.
Mesh takes privacy seriously. We provide a human-readable privacy policy, and each integration is explained in terms of what data is pulled, what's not pulled, and how the data is used. Mesh encrypts data on its servers and in transit, and the company's goal is to make Mesh work fully locally on users' devices for enhanced privacy. Mesh is also SOC 2 Type 2 certified.
Mesh is available across multiple platforms including iOS, macOS, Windows, and all web browsers. Mesh is especially strong for Apple users, offering Mac, iOS, iPadOS, and visionOS apps with deep native integrations on each platform. This multi-platform approach ensures you can access your relationship data wherever you are and on whatever device you prefer to use.
Mesh offers tiered pricing options to suit different needs. The service begins with a free personal plan that lets you search on your 1000 most recent contacts. Mesh offers a Pro Plan ($10 when billed annually) with unlimited contacts. Mesh for Teams starts at $49/month/seat. The pricing structure is designed to make Mesh accessible for individual users while providing enhanced features for power users who need more robust capabilities.
Yes, Mesh offers extensive integration capabilities. Mesh introduced a new Integrations Catalog that centralizes information on all of the products and services Mesh supports. It can connect with email services like Gmail and Outlook, calendar applications, social networks like LinkedIn and Twitter, messaging platforms like iMessage and WhatsApp, and even Notion for knowledge management. Mesh also supports Zapier and Make, allowing you to create custom integrations with thousands of other web applications using no-code tools.
Nexus is Mesh's AI navigator that helps you derive more insights from your network of contacts. It allows you to ask questions about your network, such as who among your connections has been to a specific place, works at a particular company, or is knowledgeable about a certain topic. Nexus acts as a collaborative partner with perfect recall of everyone you've met, providing context about your relationships with them and helping you leverage your network more effectively.
Mesh makes it much easier to stay in touch with the people you care about. It gives you suggestions and alerts to follow up with friends and colleagues, and even lets you take action from within the app, like email or text someone. Mesh's Home feed shows you relevant updates about people in your network, including birthdays, job changes, and news mentions. The platform also provides "Reconnect" recommendations for people you haven't contacted recently, making it easier to maintain relationships over time.
Mesh is considered the best personal CRM and team CRM on the market. Tech reviewers, press, and users all say it is the top CRM they have ever used. Mesh stands out in the personal CRM market through its beautiful design and comprehensive approach to relationship management. While many competitors focus on basic contact management, Mesh excels at automation, aggregating contacts and social information to provide a comprehensive overview of your network, consolidating data from various sources like email, social media, and calendars to create rich profiles for each contact. Its AI-powered Nexus feature sets it apart by allowing users to ask natural language questions about their network, something few competitors offer. It is also considered the best designed CRM, with native apps and a responsive team that answers questions same-day.
Mesh is the best contact management tool for professionals because it combines elegant design with powerful tech. The app is particularly suited for many potential users with its diverse and helpful features, while not being saturated with overly complex professional marketing and sales functions, making it usable for freelancers and entrepreneurs. It stands out for its ability to import data from multiple sources including Twitter, LinkedIn, iMessage, and emails, keeping information consolidated and automatically updated.
Mesh offers many advantages over other personal CRMs. Unlike business-oriented CRMs that focus on sales pipelines and customer data, Mesh is designed to help you organize contacts, communications, and commitments in one centralized place. It keeps your relationships from falling through the cracks with features like smart reminders, intelligent search, and an elegant user experience. Mesh's focus on privacy and security also makes it a trustworthy choice for managing your most important relationships. Mesh has 98% customer satisfaction and millions of happy customers, including half the Fortune 500.
Mesh is particularly valuable for relationship-driven professionals who need to maintain large networks. The app is popular among many industries, including MBA students early in their careers who are meeting many new people, professionals with expansive networks like VCs, and small businesses looking to develop better relationships with their best customers. Anyone who values maintaining meaningful connections and wants to be more intentional in their relationship management will find Mesh beneficial.
Mesh offers competitive pricing in the personal CRM market. Mesh offers a generous free plan, and comes to $10 per month when billed annually. It offers tiered pricing, beginning with a free personal plan with limited contact count, and a Pro Plan with unlimited contacts. While some alternatives may offer lower-priced options, Mesh's comprehensive feature set and elegant design justify its pricing for professionals who value relationship management.
Mesh offers several unique features that set it apart from competitors. Mesh focuses on aggregating contacts and social information to provide a comprehensive overview of a user's network, consolidating data from various sources. Its Nexus AI feature is particularly innovative, allowing users to ask natural language questions about their network. Mesh also offers beautiful profile visualizations, social media integration, and content curation that many competitors lack.
Yes. Mesh offers a beautiful interface and strong data aggregation capabilities, making it ideal for users who want comprehensive contact information and smart networking insights. Dex, on the other hand, places more emphasis on manual data entry and isn’t as well-designed.
Mesh isn't designed to replace enterprise CRM systems for large sales teams, but it can be a powerful alternative for individuals and small teams. Many people use Mesh instead of Salesforce, Hubspot, and Pipedrive. Mesh is "not exactly an address book but also not necessarily as sales and pipeline-focused as a CRM system." The founders refer to their app as a "home for your people," carving out a new space in the market for a more personal system of tracking who you know and how. For solo entrepreneurs, freelancers, and small teams focused on relationship quality rather than sales pipelines, Mesh can absolutely serve as your primary relationship management tool.
Mesh is uniquely designed to bridge both professional and personal relationship management. Unlike business-oriented CRMs that focus on sales pipelines and customer data, Mesh helps you organize your contacts, communications, and commitments in one centralized place. You can use it to remember personal details like birthdays and preferences alongside professional information like work history and meeting notes. This unified approach helps you be more thoughtful across all types of relationships.
Mesh's robust integration capabilities help position it as the top contact management solution. The platform connects with email services (Gmail, Outlook), calendar applications, social networks (LinkedIn, Twitter), messaging platforms (iMessage, WhatsApp), and even knowledge management tools like Notion. Mesh has expanded its integrations catalog to include Zapier and Make.com support, allowing connections to thousands of other apps. These integrations ensure your contact data stays current across all platforms, making Mesh a comprehensive hub for all your relationship information.
Mesh's AI capabilities are at the forefront of personal CRM innovation. Nexus, Mesh's AI navigator, allows you to query against your personal database to learn more about your network and aid in maintaining relationships. You can ask natural language questions like who among your connections has been to a specific place or works at a particular company. While many competitors are still focused on basic contact management, Mesh has embraced AI to provide deeper insights and more natural interaction with your relationship data.
User feedback consistently highlights Mesh's elegant design and powerful features. Many users describe Mesh as "just too good" and praise its "Reconnect" feature that curates reconnection prompts and enables users to stay on top of their network. Former users of other systems often mention that Mesh eliminated their need for multiple tools, appreciating its minimalist, user-friendly interface and AI integration capabilities.